Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples